Patents by Inventor Mario LOHR

Mario LOHR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220265982
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Application
    Filed: May 11, 2022
    Publication date: August 25, 2022
    Applicant: Novocure GmbH
    Inventors: Carsten HAGEMANN, Mario LOHR, Almuth F. KESSLER, Malgorzata BUREK, Carola FORSTER, Catherine BRAMI, Hadas Sara HERSHKOVICH, Tali VOLOSHIN-SELA
  • Patent number: 11400269
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: August 2, 2022
    Assignee: Novocure GmbH
    Inventors: Carsten Hagemann, Mario Lohr, Almuth F. Kessler, Malgorzata Burek, Carola Forster, Catherine Brami, Hadas Sara Hershkovich, Tali Voloshin-Sela
  • Patent number: 11351349
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: June 7, 2022
    Assignee: Novocure GmbH
    Inventors: Carsten Hagemann, Mario Lohr, Almuth F. Kessler, Malgorzata Burek, Carola Forster, Catherine Brami, Hadas Sara Hershkovich, Tali Voloshin-Sela
  • Publication number: 20210330950
    Abstract: Many drugs and other molecules cannot ordinarily traverse the blood brain barrier (BBB). However, when alternating electric fields at certain optimum frequencies (e.g., 100 kHz) are applied to the brain, the BBB becomes permeable to those molecules. When the alternating electric fields are discontinued, the BBB eventually recovers to its original impermeable state. Subsequently, re-application of alternating electric fields at the optimum frequencies will re-open the BBB. Ordinarily, many frequencies (e.g., 200 kHz) of alternating electric fields are either ineffective or less effective at inducing permeability than the optimum frequencies. But once the BBB has been opened by applying alternating electric fields at the optimum frequencies, alternating electric fields at non-optimum frequencies can maintain the permeability of a previously-opened BBB.
    Type: Application
    Filed: April 21, 2021
    Publication date: October 28, 2021
    Applicant: Novocure GmbH
    Inventors: Carsten HAGEMANN, Mario LOHR, Almuth F. KESSLER, Malgorzata BUREK, Carola FORSTER, Catherine BRAMI, Hadas Sara HERSHKOVICH, Tali VOLOSHIN-SELA
  • Patent number: 10967167
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: April 6, 2021
    Inventors: Carsten Hagemann, Mario Lohr, Almuth F. Kessler, Malgorzata Burek, Carola Forster, Catherine Brami, Hadas Sara Hershkovich, Tali Voloshin-Sela
  • Publication number: 20200269037
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 27, 2020
    Inventors: Carsten HAGEMANN, Mario LOHR, Almuth F. KESSLER, Malgorzata BUREK, Carola FORSTER, Catherine BRAMI, Hadas Sara HERSHKOVICH, Tali VOLOSHIN-SELA
  • Publication number: 20200061360
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Application
    Filed: August 22, 2019
    Publication date: February 27, 2020
    Inventors: Carsten HAGEMANN, Mario LOHR, Almuth F. KESSLER, Malgorzata BUREK, Carola FORSTER, Catherine BRAMI, Hadas Sara HERSHKOVICH, Tali VOLOSHIN-SELA
  • Publication number: 20200061361
    Abstract: Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.
    Type: Application
    Filed: August 22, 2019
    Publication date: February 27, 2020
    Inventors: Carsten HAGEMANN, Mario LOHR, Almuth F. KESSLER, Malgorzata BUREK, Carola FORSTER, Catherine BRAMI, Hadas Sara HERSHKOVICH, Tali VOLOSHIN-SELA